1. The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway
   Jiazhi Xu et al, 2022, Head & Face Medicine CrossRef